Human mature B cell lymphomas, including multiple myeloma (MM), mantle cell lymphomas (MCL) or marginal zone lymphomas (MZL), frequently harbor mutations or deletions of TRAF2, TRAF3 or BIRC3 (a.k.a. cIAP2) [12–20]. Here, BIRC3 is linked to plasma cell myeloma.